These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9304672)

  • 21. Human Genetics Society of Australasia Position Statement: Genetic Testing and Personal Insurance Products in Australia.
    Newson AJ; Ayres S; Boyle J; Gabbett MT; Nisselle A
    Twin Res Hum Genet; 2018 Dec; 21(6):533-537. PubMed ID: 30458892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-selection costs by gene tests exemplified by the BRCA gene].
    Becher J
    Versicherungsmedizin; 2000 Dec; 52(4):192-4. PubMed ID: 11142106
    [No Abstract]   [Full Text] [Related]  

  • 23. Public oppose insurers' genetic test policy.
    Genetics Forum (London)
    Splice Life; 1997 Apr; 3(5):10-1. PubMed ID: 11660515
    [No Abstract]   [Full Text] [Related]  

  • 24. Genetics and Insurance in Australia: Concerns around a Self-Regulated Industry.
    Newson AJ; Tiller J; Keogh LA; Otlowski M; Lacaze P
    Public Health Genomics; 2017; 20(4):247-256. PubMed ID: 29069661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Insurance and gene analysis].
    Raestrup O
    Versicherungsmedizin; 1990 Apr; 42(2):37-8. PubMed ID: 2110693
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic information and life insurance.
    Pokorski RJ
    Nature; 1995 Jul; 376(6535):13-4. PubMed ID: 7596420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Japanese insurers' attitudes toward adverse selection and genetic discrimination: a questionnaire survey and interviews with employees about using genetic test results.
    Iida H; Muto K
    J Hum Genet; 2021 May; 66(5):539-542. PubMed ID: 33177703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic testing, adverse selection, and the demand for life insurance.
    Zick CD; Smith KR; Mayer RN; Botkin JR
    Am J Med Genet; 2000 Jul; 93(1):29-39. PubMed ID: 10861679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TANTAMOUNT TO FRAUD?: EXPLORING NON-DISCLOSURE OF GENETIC INFORMATION IN LIFE INSURANCE APPLICATIONS AS GROUNDS FOR POLICY RESCISSION.
    Prince AE
    Health Matrix Clevel; 2016; 26():255-307. PubMed ID: 27263254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular screening for familial hypercholesterolaemia: consequences for life and disability insurance.
    Homsma SJ; Huijgen R; Middeldorp S; Sijbrands EJ; Kastelein JJ
    Eur J Hum Genet; 2008 Jan; 16(1):14-7. PubMed ID: 17957228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human Genetics Advisory Commission meets.
    Gene Ther; 1997 Apr; 4(4):271. PubMed ID: 11644931
    [No Abstract]   [Full Text] [Related]  

  • 33. A survey of state insurance commissioners concerning genetic testing and life insurance.
    McEwen JE; McCarty K; Reilly PR
    Am J Hum Genet; 1992 Oct; 51(4):785-92. PubMed ID: 1307229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Death and disability benefits: effective financial management.
    Jacobsen ML
    Top Health Care Financ; 1986; 12(4):84-90. PubMed ID: 2941898
    [No Abstract]   [Full Text] [Related]  

  • 35. Validation of genetic tests for insurance in UK.
    Kleinert S
    Lancet; 1998 Nov; 352(9140):1608. PubMed ID: 11660514
    [No Abstract]   [Full Text] [Related]  

  • 36. Insurers backtrack on gene tests demands.
    Coghlan A
    New Sci; 2001 May; 170(2290):14. PubMed ID: 11885640
    [No Abstract]   [Full Text] [Related]  

  • 37. [Genetic screening of patients with familial hypercholesterolemia and insurability for life insurance policies and disability cover policies].
    Homsma SJ; Lansberg PJ; Kastelein JJ
    Ned Tijdschr Geneeskd; 2004 Mar; 148(10):493-6. PubMed ID: 15042898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetics revolution hampered by insurance fears.
    Berger A
    New Sci; 1995 Jul; 147(1987):8. PubMed ID: 11660087
    [No Abstract]   [Full Text] [Related]  

  • 39. Life and health insurance behaviour of individuals having undergone a predictive genetic testing programme for hereditary non-polyposis colorectal cancer.
    Aktan-Collan K; Haukkala A; Kaariainen H
    Community Genet; 2001; 4(4):219-24. PubMed ID: 12751485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquisition and disclosure of genetic information under alternative policy regimes: an economic analysis.
    Wilson D
    Health Econ Policy Law; 2006 Jul; 1(Pt 3):263-76. PubMed ID: 18634696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.